Clustering O
of O
missense O
mutations O
in O
the O
ataxia O
- O
telangiectasia O
gene O
in O
a O
sporadic B
T I
- I
cell I
leukaemia I
. O

By O
analysing O
tumour O
DNA O
from O
patients O
with O
sporadic B
T I
- I
cell I
prolymphocytic I
leukaemia I
( O
T B
- I
PLL I
) O
, O
a O
rare O
clonal B
malignancy I
with O
similarities O
to O
a O
mature B
T I
- I
cell I
leukaemia I
seen O
in O
A O
- O
T O
, O
we O
demonstrate O
a O
high O
frequency O
of O
ATM O
mutations O
in O
T B
- I
PLL I
. O

Two O
of O
seventeen O
mutated O
T B
- I
PLL I
samples O
had O
a O
previously O
reported O
A O
- O
T O
allele O
. O

The O
evidence O
of O
a O
significant O
proportion O
of O
loss O
- O
of O
- O
function O
mutations O
and O
a O
complete O
absence O
of O
the O
normal O
copy O
of O
ATM O
in O
the O
majority O
of O
mutated O
tumours O
establishes O
somatic O
inactivation O
of O
this O
gene O
in O
the O
pathogenesis O
of O
sporadic B
T I
- I
PLL I
and O
suggests O
that O
ATM O
acts O
as O
a O
tumour O
suppressor O
. O

As O
constitutional O
DNA O
was O
not O
available O
, O
a O
putative O
hereditary O
predisposition O
to O
T B
- I
PLL I
will O
require O
further O
investigation O
. O
. O

Autosomal B
dominant I
neurohypophyseal I
diabetes I
insipidus I
associated O
with O
a O
missense O
mutation O
encoding O
Gly23 O
- O
- O
> O
Val O
in O
neurophysin O
II O
. O

Sporadic O
prostate O
carcinoma O
is O
the O
most O
common O
male B
cancer I
in O
the O
Western O
world O
, O
yet O
many O
of O
the O
major O
genetic O
events O
involved O
in O
the O
progression O
of O
this O
often O
fatal O
cancer O
remain O
to O
be O
elucidated O
. O

The O
RB1 O
gene O
mutation O
was O
investigated O
in O
a O
child O
with O
ectopic O
intracranial O
retinoblastoma O
using O
DNA O
obtained O
from O
both O
the O
pineal B
and I
retinal I
tumours I
of O
the O
patient O
. O

A O
nonsense O
mutation O
in O
exon O
17 O
( O
codon O
556 O
) O
of O
the O
RB1 O
gene O
was O
found O
to O
be O
present O
homozygously O
in O
both O
the O
retinal B
and I
the I
pineal I
tumours I
. O

Though O
auditory B
anomalies I
have O
been O
observed O
in O
mice O
with O
dominant O
white O
spotting O
( O
W O
) O
due O
to O
KIT O
mutations O
, O
deafness O
is O
not O
typical O
in O
human O
piebaldism O
. O

Thus O
, O
the O
occurrence O
of O
sensorineural O
deafness O
in O
this O
patient O
extends O
considerably O
the O
phenotypic O
range O
of O
piebaldism O
due O
to O
KIT O
gene O
mutation O
in O
humans O
and O
tightens O
the O
clinical O
similarity O
between O
piebaldism O
and O
the O
various O
forms O
of O
Waardenburg B
syndrome I
. O
. O

Cycloheximide O
facilitates O
the O
identification O
of O
aberrant O
transcripts O
resulting O
from O
a O
novel O
splice O
- O
site O
mutation O
in O
COL17A1 O
in O
a O
patient O
with O
generalized O
atrophic B
benign I
epidermolysis I
bullosa I
. O

Patients O
with O
generalized O
atrophic B
benign I
epidermolysis I
bullosa I
often O
show O
decreased O
expression O
of O
type O
XVII O
collagen O
, O
a O
transmembrane O
hemidesmosomal O
protein O
encoded O
by O
COL17A1 O
. O

This O
report O
documents O
a O
novel O
splice O
- O
site O
mutation O
in O
COL17A1 O
in O
a O
patient O
with O
generalized O
atrophic B
benign I
epidermolysis I
bullosa I
, O
and O
applies O
a O
new O
methodology O
to O
define O
and O
characterize O
the O
resulting O
mRNA O
splice O
variants O
. O

A O
deletion O
mutation O
in O
COL17A1 O
in O
five O
Austrian O
families O
with O
generalized O
atrophic B
benign I
epidermolysis I
bullosa I
represents O
propagation O
of O
an O
ancestral O
allele O
. O

Patients O
with O
generalized O
atrophic B
benign I
epidermolysis I
bullosa I
, O
a O
usually O
nonlethal O
form O
of O
junctional B
epidermolysis I
bullosa I
, O
have O
generalized O
blistering B
, O
nail B
dystrophy I
, O
patchy B
alopecia I
, O
and O
dental O
abnormalities O
. O

Skin B
fragility I
in O
most O
cases O
is O
due O
to O
mutations O
in O
the O
gene O
encoding O
type O
XVII O
collagen O
( O
COL17A1 O
) O
. O

Recently O
, O
we O
reported O
five O
Austrian O
families O
with O
generalized O
atrophic B
benign I
epidermolysis I
bullosa I
who O
share O
the O
same O
COL17A1 O
mutation O
. O

Mutation O
spectrum O
and O
genotype O
- O
phenotype O
analyses O
in O
Cowden B
disease I
and O
Bannayan B
- I
Zonana I
syndrome I
, O
two O
hamartoma B
syndromes I
with O
germline O
PTEN O
mutation O
. O

Somatic O
PTEN O
deletions O
and O
mutations O
were O
observed O
in O
sporadic O
breast O
, O
brain O
, O
prostate O
and O
kidney O
cancer O
cell O
lines O
and O
in O
several O
primary O
tumours O
such O
as O
endometrial O
carcinomas O
, O
malignant O
melanoma O
and O
thyroid B
tumours I
. O

In O
addition O
, O
PTEN O
was O
identified O
as O
the O
susceptibility O
gene O
for O
two O
hamartoma B
syndromes I
Cowden B
disease I
( O
CD B
; O
MIM O
158350 O
) O
and O
Bannayan B
- I
Zonana I
( I
BZS I
) I
or I
Ruvalcaba I
- I
Riley I
- I
Smith I
syndrome I
( O
MIM O
153480 O
) O
. O

Constitutive O
DNA O
from O
37 O
CD B
families O
and O
seven O
BZS B
families O
was O
screened O
for O
germline O
PTEN O
mutations O
. O

PTEN O
mutations O
were O
identified O
in O
30 O
of O
37 O
( O
81 O
% O
) O
CD B
families O
, O
including O
missense O
and O
nonsense O
point O
mutations O
, O
deletions O
, O
insertions O
, O
a O
deletion O
/ O
insertion O
and O
splice O
site O
mutations O
. O

A O
hot O
spot O
for O
PTEN O
mutation O
in O
CD B
was O
identified O
in O
exon O
5 O
that O
contains O
the O
PTPase O
core O
motif O
, O
with O
13 O
of O
30 O
( O
43 O
% O
) O
CD B
mutations O
identified O
in O
this O
exon O
. O

Germline O
PTEN O
mutations O
were O
identified O
in O
four O
of O
seven O
( O
57 O
% O
) O
BZS B
families O
studied O
. O

It O
is O
also O
worthy O
of O
note O
that O
a O
single O
nonsense O
point O
mutation O
, O
R233X O
, O
was O
observed O
in O
the O
germline O
DNA O
from O
two O
unrelated O
CD B
families O
and O
one O
BZS B
family O
. O

Genotype O
- O
phenotype O
studies O
were O
not O
performed O
on O
this O
small O
group O
of O
BZS B
families O
. O

However O
, O
genotype O
- O
phenotype O
analysis O
inthe O
group O
of O
CD B
families O
revealed O
two O
possible O
associations O
worthy O
of O
follow O
- O
up O
in O
independent O
analyses O
. O

The O
first O
was O
an O
association O
noted O
in O
the O
group O
of O
CD B
families O
with O
breast B
disease I
. O

Specifically O
and O
more O
directly O
, O
an O
association O
was O
also O
observed O
between O
the O
presence O
of O
a O
PTEN O
mutation O
and O
malignant B
breast I
disease I
. O

However O
, O
these O
observations O
would O
need O
to O
be O
confirmed O
by O
studying O
a O
larger O
number O
of O
CD B
families O
. O

Mutations O
in O
PAX6 O
are O
responsible O
for O
human O
aniridia O
and O
have O
also O
been O
found O
in O
patients O
with O
Peters O
anomaly O
, O
with O
congenital O
cataracts O
, O
with O
autosomal B
dominant I
keratitis I
, O
and O
with O
isolated O
foveal O
hypoplasia O
. O

Eye O
movement O
abnormalities O
correlate O
with O
genotype O
in O
autosomal O
dominant O
cerebellar B
ataxia I
type I
I I
. O

We O
compared O
horizontal O
eye O
movements O
( O
visually O
guided O
saccades O
, O
antisaccades O
, O
and O
smooth O
pursuit O
) O
in O
control O
subjects O
( O
n O
= O
14 O
) O
and O
patients O
with O
three O
forms O
of O
autosomal O
dominant O
cerebellar B
ataxias I
type I
I I
spinocerebellar B
ataxias I
1 I
and I
2 I
( O
SCA1 B
, O
n O
= O
11 O
; O
SCA2 B
, O
n O
= O
10 O
) O
and O
SCA3 O
/ O
Machado O
- O
Joseph O
disease O
( O
MJD O
) O
( O
n O
= O
16 O
) O
. O

In O
SCA1 B
, O
saccade O
amplitude O
was O
significantly O
increased O
, O
resulting O
in O
hypermetria O
. O

In O
SCA2 B
, O
saccade O
velocity O
was O
markedly O
decreased O
. O

In O
SCA3 O
, O
gaze B
- I
evoked I
nystagmus I
was O
often O
present O
as O
was O
saccade O
hypometria O
and O
smooth O
pursuit O
gain O
was O
markedly O
decreased O
. O

Three O
major O
criteria O
, O
saccade O
amplitude O
, O
saccade O
velocity O
, O
and O
presence O
of O
gaze B
- I
evoked I
nystagmus I
, O
permitted O
the O
correct O
assignment O
of O
90 O
% O
of O
the O
SCA1 B
, O
90 O
% O
of O
the O
SCA2 B
, O
and O
93 O
% O
of O
the O
patients O
with O
SCA3 O
to O
their O
genetically O
confirmed O
patient O
group O
and O
, O
therefore O
, O
may O
help O
orient O
diagnoses O
of O
SCA1 B
, O
SCA2 B
, O
and O
SCA3 O
at O
early O
clinical O
stages O
of O
the O
diseases O
. O
. O

Ventricular B
fibrillation I
causes O
more O
than O
300 O
, O
000 O
sudden O
deaths O
each O
year O
in O
the O
USA O
alone O
. O

Genetic O
heterogeneity O
of O
Saethre B
- I
Chotzen I
syndrome I
, O
due O
to O
TWIST O
and O
FGFR O
mutations O
. O

Thirty O
- O
two O
unrelated O
patients O
with O
features O
of O
Saethre B
- I
Chotzen I
syndrome I
, O
a O
common O
autosomal O
dominant O
condition O
of O
craniosynostosis B
and O
limb O
anomalies O
, O
were O
screened O
for O
mutations O
in O
TWIST O
, O
FGFR2 O
, O
and O
FGFR3 O
. O

To O
date O
, O
our O
detection O
rate O
for O
TWIST O
or O
FGFR O
mutations O
is O
68 O
% O
in O
our O
Saethre B
- I
Chotzen I
syndrome I
patients O
, O
including O
our O
five O
patients O
elsewhere O
reported O
with O
TWIST O
mutations O
. O

The O
most O
common O
phenotypic O
features O
, O
present O
in O
more O
than O
a O
third O
of O
our O
patients O
with O
TWIST O
mutations O
, O
are O
coronal B
synostosis I
, O
brachycephaly B
, O
low O
frontal O
hairline O
, O
facial B
asymmetry I
, O
ptosis B
, O
hypertelorism O
, O
broad B
great I
toes I
, O
and O
clinodactyly B
. O

The O
overlap O
in O
clinical O
features O
and O
the O
presence O
, O
in O
the O
same O
genes O
, O
of O
mutations O
for O
more O
than O
one O
craniosynostotic B
condition I
- O
such O
as O
Saethre B
- I
Chotzen I
, I
Crouzon I
, I
and I
Pfeiffer I
syndromes I
- O
support O
the O
hypothesis O
that O
TWIST O
and O
FGFRs O
are O
components O
of O
the O
same O
molecular O
pathway O
involved O
in O
the O
modulation O
of O
craniofacial O
and O
limb O
development O
in O
humans O
. O
. O

Hemochromatosis O
, O
the O
inherited B
disorder I
of I
iron I
metabolism I
, O
leads O
, O
if O
untreated O
, O
to O
progressive O
iron O
overload O
and O
premature B
death I
. O

In O
contrast O
, O
WT1 O
missense O
mutations O
, O
associated O
with O
male B
pseudohermaphroditism I
in O
Denys O
- O
Drash O
syndrome O
, O
fail O
to O
synergize O
with O
SF O
- O
1 O
. O

W474C O
amino O
acid O
substitution O
affects O
early O
processing O
of O
the O
alpha O
- O
subunit O
of O
beta O
- O
hexosaminidase O
A O
and O
is O
associated O
with O
subacute O
G B
( I
M2 I
) I
gangliosidosis I
. O

Mutations O
in O
the O
HEXA O
gene O
, O
encoding O
the O
alpha O
- O
subunit O
of O
beta O
- O
hexosaminidase O
A O
( O
Hex O
A O
) O
, O
that O
abolish O
Hex O
A O
enzyme O
activity O
cause O
Tay O
- O
Sachs O
disease O
( O
TSD O
) O
, O
the O
fatal O
infantile B
form I
of I
G I
( I
M2 I
) I
gangliosidosis I
, I
Type I
1 I
. O

We O
identified O
a O
1422 O
G O
- O
- O
> O
C O
( O
amino O
acid O
W474C O
) O
substitution O
in O
the O
first O
position O
of O
exon O
13 O
of O
HEXA O
of O
a O
non O
- O
Jewish O
proband O
who O
manifested O
a O
subacute O
variant O
of O
G B
( I
M2 I
) I
gangliosidosis I
. O

Insertional O
mutation O
by O
transposable O
element O
, O
L1 O
, O
in O
the O
DMD O
gene O
results O
in O
X B
- I
linked I
dilated I
cardiomyopathy I
. O

X B
- I
linked I
dilated I
cardiomyopathy I
( O
XLDCM B
) O
is O
a O
clinical O
phenotype O
of O
dystrophinopathy O
which O
is O
characterized O
by O
preferential O
myocardial O
involvement O
without O
any O
overt O
clinical O
signs O
of O
skeletal O
myopathy O
. O

To O
date O
, O
several O
mutations O
in O
the O
Duchenne O
muscular O
dystrophy O
gene O
, O
DMD O
, O
have O
been O
identified O
in O
patients O
with O
XLDCM B
, O
but O
a O
pathogenic O
correlation O
of O
these O
cardiospecific O
mutations O
in O
DMD O
with O
the O
XLDCM B
phenotype O
has O
remained O
to O
be O
elucidated O
. O

We O
report O
here O
the O
identification O
of O
a O
unique O
de O
novo O
L1 O
insertion O
in O
the O
muscle O
exon O
1 O
in O
DMD O
in O
three O
XLDCM B
patients O
from O
two O
unrelated O
Japanese O
families O
. O

We O
speculate O
that O
this O
insertion O
of O
an O
L1 O
sequence O
in O
DMD O
is O
responsible O
for O
some O
of O
the O
population O
of O
Japanese O
patients O
with O
XLDCM B
. O
. O

While O
a O
few O
cases O
of O
isolated O
ACTH B
deficiency I
have O
been O
reported O
( O
OMIM O
201400 O
) O
, O
an O
inherited O
POMC O
defect O
has O
not O
been O
described O
so O
far O
. O

The O
dual O
role O
of O
alpha O
- O
MSH O
in O
regulating O
food O
intake O
and O
influencing O
hair O
pigmentation O
predicts O
that O
the O
phenotype O
associated O
with O
a O
defect O
in O
POMC O
function O
would O
include O
obesity O
, O
alteration O
in O
pigmentation O
and O
ACTH B
deficiency I
. O

Schwartz B
- I
Jampel I
syndrome I
type I
2 I
and O
Stuve B
- I
Wiedemann I
syndrome I
: O
a O
case O
for O
" O
lumping O
" O
. O

Recent O
studies O
demonstrated O
the O
existence O
of O
a O
genetically O
distinct O
, O
usually O
lethal O
form O
of O
the O
Schwartz O
- O
Jampel O
syndrome O
( O
SJS O
) O
of O
myotonia O
and O
skeletal B
dysplasia I
, O
which O
we O
called O
SJS B
type I
2 I
. O

This O
disorder O
is O
reminiscent O
of O
another O
rare O
condition O
, O
the O
Stuve B
- I
Wiedemann I
syndrome I
( O
SWS B
) O
, O
which O
comprises O
campomelia B
at O
birth O
with O
skeletal B
dysplasia I
, O
contractures O
, O
and O
early B
death I
. O

To O
test O
for O
possible O
nosologic O
identity O
between O
these O
disorders O
, O
we O
reviewed O
the O
literature O
and O
obtained O
a O
follow O
- O
up O
of O
the O
only O
two O
surviving O
patients O
, O
one O
with O
SJS B
type I
2 I
at O
age O
10 O
years O
and O
another O
with O
SWS B
at O
age O
7 O
years O
. O

Patients O
reported O
as O
having O
either O
neonatal O
SJS O
or O
SWS B
presented O
a O
combination O
of O
a O
severe O
, O
prenatal O
- O
onset O
neuromuscular O
disorder O
( O
with O
congenital O
joint O
contractures O
, O
respiratory O
and O
feeding O
difficulties O
, O
tendency O
to O
hyperthermia O
, O
and O
frequent O
death O
in O
infancy O
) O
with O
a O
distinct O
campomelic B
- I
metaphyseal I
skeletal I
dysplasia I
. O

The O
follow O
- O
up O
observation O
of O
an O
identical O
and O
unique O
pattern O
of O
progressive O
bone B
dysplasia I
in O
the O
two O
patients O
( O
one O
with O
SJS B
type I
2 I
, O
one O
with O
SWS B
) O
surviving O
beyond O
infancy O
adds O
to O
the O
evidence O
in O
favor O
of O
identity O
. O

The O
hypothesis O
that O
SWS B
and O
SJS B
type I
2 I
are O
the O
same O
disorder O
should O
be O
testable O
by O
molecular O
methods O
. O
. O

von B
Willebrand I
factor I
( I
vWf I
) I
deficiency I
causes O
severe O
von O
Willebrand O
disease O
in O
humans O
. O

vWf B
- I
deficient I
mice O
appeared O
normal O
at O
birth O
; O
they O
were O
viable O
and O
fertile O
. O

Defective O
thrombosis O
in O
mutant O
mice O
was O
also O
evident O
in O
an O
in O
vivo O
model O
of O
vascular B
injury I
. O

Heterozygous O
mutations O
in O
the O
human O
PAX6 O
gene O
result O
in O
various O
phenotypes O
, O
including O
aniridia O
, O
Peters O
anomaly O
, O
autosomal B
dominant I
keratitis I
, O
and O
familial O
foveal O
dysplasia O
. O

Genomic O
structure O
of O
the O
human O
congenital B
chloride I
diarrhea I
( O
CLD B
) O
gene O
. O

Congenital B
chloride I
diarrhea I
( O
CLD B
) O
is O
caused O
by O
mutations O
in O
a O
gene O
which O
encodes O
an O
intestinal O
anion O
transporter O
. O

We O
report O
here O
the O
complete O
genomic O
organization O
of O
the O
human O
CLD B
gene O
which O
spans O
approximately O
39kb O
, O
and O
comprises O
21 O
exons O
. O

The O
genomic O
structure O
was O
determined O
using O
DNA O
from O
several O
sources O
including O
multiple O
large O
- O
insert O
libaries O
and O
genomic O
DNA O
from O
Finnish O
CLD B
patients O
and O
controls O
. O

Genomic O
sequencing O
of O
a O
BAC O
clone O
H O
_ O
RG364P16 O
revealed O
the O
presence O
of O
another O
, O
highly O
homologous O
gene O
3 O
of O
the O
CLD B
gene O
, O
with O
a O
similar O
genomic O
structure O
, O
recently O
identified O
as O
the O
Pendred O
syndrome O
gene O
( O
PDS O
) O
. O
. O

Down O
- O
regulation O
of O
transmembrane O
carbonic O
anhydrases O
in O
renal B
cell I
carcinoma I
cell O
lines O
by O
wild O
- O
type O
von O
Hippel O
- O
Lindau O
transgenes O
. O

Determination O
of O
the O
genomic O
structure O
of O
the O
COL4A4 O
gene O
and O
of O
novel O
mutations O
causing O
autosomal B
recessive I
Alport I
syndrome I
. O

Autosomal B
recessive I
Alport I
syndrome I
is O
a O
progressive O
hematuric O
glomerulonephritis O
characterized O
by O
glomerular O
basement O
membrane O
abnormalities O
and O
associated O
with O
mutations O
in O
either O
the O
COL4A3 O
or O
the O
COL4A4 O
gene O
, O
which O
encode O
the O
alpha3 O
and O
alpha4 O
type O
IV O
collagen O
chains O
, O
respectively O
. O

We O
report O
here O
the O
complete O
characterization O
of O
the O
48 O
exons O
of O
the O
COL4A4 O
gene O
, O
a O
comprehensive O
gene O
screen O
, O
and O
the O
subsequent O
detection O
of O
10 O
novel O
mutations O
in O
eight O
patients O
diagnosed O
with O
autosomal B
recessive I
Alport I
syndrome I
. O

Identification O
of O
a O
novel O
mutation O
of O
the O
CPO O
gene O
in O
a O
Japanese O
hereditary B
coproporphyria I
family O
. O

Hereditary B
coproporphyria I
( O
HCP B
) O
is O
an O
autosomal O
dominant O
disease O
characterized O
by O
a O
deficiency B
of I
coproporphyrinogen I
oxidase I
( O
CPO O
) O
caused O
by O
a O
mutation O
in O
the O
CPO O
gene O
. O

Only O
11 O
mutations O
of O
the O
gene O
have O
been O
reported O
in O
HCP B
patients O
. O

Human B
complement I
factor I
H I
deficiency I
associated O
with O
hemolytic B
uremic I
syndrome I
. O

This O
study O
reports O
on O
six O
cases O
of O
deficiency B
in I
the I
human I
complement I
regulatory I
protein I
Factor I
H I
( O
FH O
) O
in O
the O
context O
of O
an O
acute O
renal O
disease O
. O

Five O
of O
the O
cases O
were O
observed O
in O
children O
presenting O
with O
idiopathic O
hemolytic B
uremic I
syndrome I
( O
HUS B
) O
. O

Factor B
H I
deficiency I
is O
the O
only O
complement O
deficiency O
associated O
with O
HUS B
. O

These O
observations O
suggest O
a O
role O
for O
FH O
and O
/ O
or O
FH O
receptors O
in O
the O
pathogenesis O
of O
idiopathic O
HUS B
. O
. O

Bipolar O
affective O
disorder O
( O
BPAD O
; O
manic O
- O
depressive O
illness O
) O
is O
characterized O
by O
episodes O
of O
mania O
and O
/ O
or O
hypomania B
interspersed O
with O
periods O
of O
depression B
. O

These O
findings O
are O
consistent O
with O
the O
hypothesis O
that O
certain O
alleles O
could O
prevent O
or O
modify O
the O
clinical O
manifestations O
of O
BPAD O
and O
perhaps O
other O
related O
affective B
disorders I
. O

If O
untreated O
, O
hemochromatosis O
can O
cause O
serious O
illness O
and O
early B
death I
, O
but O
the O
disease O
is O
still O
substantially O
under O
- O
diagnosed O
. O

Systematic O
analysis O
of O
coproporphyrinogen O
oxidase O
gene O
defects O
in O
hereditary B
coproporphyria I
and O
mutation O
update O
. O

Hereditary B
coproporphyria I
( O
HC B
) O
is O
an O
acute O
hepatic B
porphyria I
with O
autosomal O
dominant O
inheritance O
caused O
by O
deficient B
activity I
of I
coproporphyrinogen I
III I
oxidase I
( O
CPO O
) O
. O

The O
seven O
exons O
, O
the O
exon O
/ O
intron O
boundaries O
and O
part O
of O
3 O
noncoding O
sequence O
of O
the O
CPO O
gene O
were O
systematically O
analyzed O
by O
an O
exon O
- O
by O
- O
exon O
denaturing O
gradient O
gel O
electrophoresis O
( O
DGGE O
) O
strategy O
followed O
by O
direct O
sequencing O
in O
seven O
unrelated O
heterozygous O
HC B
patients O
from O
France O
, O
Holland O
, O
and O
Czech O
Republic O
. O

Five O
intragenic O
dimorphisms O
are O
now O
well O
characterized O
and O
the O
high O
degree O
of O
allelic O
heterogeneity O
in O
HC B
is O
demonstrated O
with O
seven O
new O
different O
mutations O
making O
a O
total O
of O
nineteen O
CPO O
gene O
defects O
reported O
so O
far O
. O
. O

Human O
MLH1 O
deficiency O
predisposes O
to O
hematological O
malignancy O
and O
neurofibromatosis B
type I
1 I
. O

We O
have O
identified O
three O
offspring O
in O
a O
hereditary O
nonpolyposis O
colorectal O
cancer O
family O
who O
developed O
hematological O
malignancy O
at O
a O
very O
early O
age O
, O
and O
at O
least O
two O
of O
them O
displayed O
signs O
of O
neurofibromatosis B
type I
1 I
( O
NF1 B
) O
. O

Thus O
, O
a O
homozygous O
germ O
- O
line O
MLH1 O
mutation O
and O
consequent O
mismatch O
repair O
deficiency O
results O
in O
a O
mutator O
phenotype O
characterized O
by O
leukemia O
and O
/ O
or O
lymphoma O
associated O
with O
neurofibromatosis B
type I
1 I
. O
. O

Here O
we O
present O
four O
novel O
PAX6 O
missense O
mutations O
, O
two O
in O
association O
with O
atypical O
phenotypes O
ectopia B
pupillae I
( O
displaced B
pupils I
) O
and O
congenital B
nystagmus I
( O
searching B
gaze I
) O
, O
and O
two O
in O
association O
with O
more O
recognizable O
aniridia O
phenotypes O
. O

These O
results O
would O
not O
be O
expected O
if O
immunostaining O
at O
intercalated O
discs O
were O
due O
to O
a O
product O
of O
the O
emerin O
gene O
and O
, O
therefore O
, O
cast O
some O
doubt O
upon O
the O
hypothesis O
that O
cardiac B
defects I
in O
EDMD O
are O
caused O
by O
absence O
of O
emerin O
from O
intercalated O
discs O
. O

Genetic O
mapping O
of O
the O
copper B
toxicosis I
locus O
in O
Bedlington O
terriers O
to O
dog O
chromosome O
10 O
, O
in O
a O
region O
syntenic O
to O
human O
chromosome O
region O
2p13 O
- O
p16 O
. O

The O
ATP7B O
gene O
has O
been O
excluded O
in O
the O
much O
rarer O
human O
copper O
overload O
disease O
non B
- I
Indian I
childhood I
cirrhosis I
, O
indicating O
genetic O
heterogeneity O
. O

By O
investigating O
the O
common O
autosomal O
recessive O
copper B
toxicosis I
( O
CT B
) O
in O
Bedlington O
terriers O
, O
we O
have O
identified O
a O
new O
locus O
involved O
in O
progressive O
liver O
disease O
. O

We O
examined O
whether O
the O
WD O
gene O
ATP7B O
was O
also O
causative O
for O
CT B
by O
investigating O
the O
chromosomal O
co O
- O
localization O
of O
ATP7B O
and O
C04107 O
, O
using O
fluorescence O
in O
situ O
hybridization O
( O
FISH O
) O
. O

C04107 O
is O
an O
anonymous O
microsatellite O
marker O
closely O
linked O
to O
CT B
. O

However O
, O
BAC O
clones O
containing O
ATP7B O
and O
C04107 O
mapped O
to O
the O
canine O
chromosome O
regions O
CFA22q11 O
and O
CFA10q26 O
, O
respectively O
, O
demonstrating O
that O
WD O
cannot O
be O
homologous O
to O
CT B
. O

The O
copper O
transport O
genes O
CTR1 O
and O
CTR2 O
were O
also O
excluded O
as O
candidate O
genes O
for O
CT B
since O
they O
both O
mapped O
to O
canine O
chromosome O
region O
CFA11q22 O
. O

Immunohistochemical O
staining O
of O
human O
breast O
specimens O
also O
revealed O
BRCA1 O
nuclear O
foci O
in O
benign O
breast O
, O
invasive B
lobular I
cancers I
and O
low B
- I
grade I
ductal I
carcinomas I
. O

Conversely O
, O
BRCA1 O
expression O
was O
reduced O
or O
undetectable O
in O
the O
majority O
of O
high O
- O
grade O
, O
ductal B
carcinomas I
, O
suggesting O
that O
absence O
of O
BRCA1 O
may O
contribute O
to O
the O
pathogenesis O
of O
a O
significant O
percentage O
of O
sporadic O
breast O
cancers O
. O
. O

